Motif 1224 (n=42)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
O75179 | ANKRD17 | T5 | ochoa | Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) | Could play pivotal roles in cell cycle and DNA regulation (PubMed:19150984). Involved in innate immune defense against viruse by positively regulating the viral dsRNA receptors DDX58 and IFIH1 signaling pathways (PubMed:22328336). Involves in NOD2- and NOD1-mediated responses to bacteria suggesting a role in innate antibacterial immune pathways too (PubMed:23711367). Target of enterovirus 71 which is the major etiological agent of HFMD (hand, foot and mouth disease) (PubMed:17276651). Could play a central role for the formation and/or maintenance of the blood vessels of the circulation system (By similarity). {ECO:0000250|UniProtKB:Q99NH0, ECO:0000269|PubMed:17276651, ECO:0000269|PubMed:19150984, ECO:0000269|PubMed:22328336, ECO:0000269|PubMed:23711367}. |
O75312 | ZPR1 | S4 | ochoa | Zinc finger protein ZPR1 (Zinc finger protein 259) | Acts as a signaling molecule that communicates proliferative growth signals from the cytoplasm to the nucleus. It is involved in the positive regulation of cell cycle progression (PubMed:29851065). Plays a role for the localization and accumulation of the survival motor neuron protein SMN1 in sub-nuclear bodies, including gems and Cajal bodies. Induces neuron differentiation and stimulates axonal growth and formation of growth cone in spinal cord motor neurons. Plays a role in the splicing of cellular pre-mRNAs. May be involved in H(2)O(2)-induced neuronal cell death. {ECO:0000269|PubMed:11283611, ECO:0000269|PubMed:17068332, ECO:0000269|PubMed:22422766, ECO:0000269|PubMed:29851065}. |
O75340 | PDCD6 | Y4 | ochoa | Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2) | Calcium sensor that plays a key role in processes such as endoplasmic reticulum (ER)-Golgi vesicular transport, endosomal biogenesis or membrane repair. Acts as an adapter that bridges unrelated proteins or stabilizes weak protein-protein complexes in response to calcium: calcium-binding triggers exposure of apolar surface, promoting interaction with different sets of proteins thanks to 3 different hydrophobic pockets, leading to translocation to membranes (PubMed:20691033, PubMed:25667979). Involved in ER-Golgi transport by promoting the association between PDCD6IP and TSG101, thereby bridging together the ESCRT-III and ESCRT-I complexes (PubMed:19520058). Together with PEF1, acts as a calcium-dependent adapter for the BCR(KLHL12) complex, a complex involved in ER-Golgi transport by regulating the size of COPII coats (PubMed:27716508). In response to cytosolic calcium increase, the heterodimer formed with PEF1 interacts with, and bridges together the BCR(KLHL12) complex and SEC31 (SEC31A or SEC31B), promoting monoubiquitination of SEC31 and subsequent collagen export, which is required for neural crest specification (PubMed:27716508). Involved in the regulation of the distribution and function of MCOLN1 in the endosomal pathway (PubMed:19864416). Promotes localization and polymerization of TFG at endoplasmic reticulum exit site (PubMed:27813252). Required for T-cell receptor-, Fas-, and glucocorticoid-induced apoptosis (By similarity). May mediate Ca(2+)-regulated signals along the death pathway: interaction with DAPK1 can accelerate apoptotic cell death by increasing caspase-3 activity (PubMed:16132846). Its role in apoptosis may however be indirect, as suggested by knockout experiments (By similarity). May inhibit KDR/VEGFR2-dependent angiogenesis; the function involves inhibition of VEGF-induced phosphorylation of the Akt signaling pathway (PubMed:21893193). In case of infection by HIV-1 virus, indirectly inhibits HIV-1 production by affecting viral Gag expression and distribution (PubMed:27784779). {ECO:0000250|UniProtKB:P12815, ECO:0000269|PubMed:16132846, ECO:0000269|PubMed:19520058, ECO:0000269|PubMed:19864416, ECO:0000269|PubMed:20691033, ECO:0000269|PubMed:21893193, ECO:0000269|PubMed:25667979, ECO:0000269|PubMed:27716508, ECO:0000269|PubMed:27784779, ECO:0000269|PubMed:27813252}.; FUNCTION: [Isoform 2]: Has a lower Ca(2+) affinity than isoform 1 (By similarity). {ECO:0000250|UniProtKB:P12815}. |
P06400 | RB1 | T5 | psp | Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110) | Tumor suppressor that is a key regulator of the G1/S transition of the cell cycle (PubMed:10499802). The hypophosphorylated form binds transcription regulators of the E2F family, preventing transcription of E2F-responsive genes (PubMed:10499802). Both physically blocks E2Fs transactivating domain and recruits chromatin-modifying enzymes that actively repress transcription (PubMed:10499802). Cyclin and CDK-dependent phosphorylation of RB1 induces its dissociation from E2Fs, thereby activating transcription of E2F responsive genes and triggering entry into S phase (PubMed:10499802). RB1 also promotes the G0-G1 transition upon phosphorylation and activation by CDK3/cyclin-C (PubMed:15084261). Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity). {ECO:0000250|UniProtKB:P13405, ECO:0000250|UniProtKB:P33568, ECO:0000269|PubMed:10499802, ECO:0000269|PubMed:15084261}.; FUNCTION: (Microbial infection) In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity. {ECO:0000269|PubMed:1316611, ECO:0000269|PubMed:17974914, ECO:0000269|PubMed:18701596, ECO:0000269|PubMed:2839300, ECO:0000269|PubMed:8892909}. |
P10412 | H1-4 | T4 | ochoa | Histone H1.4 (Histone H1b) (Histone H1s-4) | Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Also acts as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}. |
P16157 | ANK1 | S4 | ochoa | Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) | Component of the ankyrin-1 complex, a multiprotein complex involved in the stability and shape of the erythrocyte membrane (PubMed:35835865). Attaches integral membrane proteins to cytoskeletal elements; binds to the erythrocyte membrane protein band 4.2, to Na-K ATPase, to the lymphocyte membrane protein GP85, and to the cytoskeletal proteins fodrin, tubulin, vimentin and desmin. Erythrocyte ankyrins also link spectrin (beta chain) to the cytoplasmic domain of the erythrocytes anion exchange protein; they retain most or all of these binding functions. {ECO:0000269|PubMed:12456646, ECO:0000269|PubMed:35835865}.; FUNCTION: [Isoform Mu17]: Together with obscurin in skeletal muscle may provide a molecular link between the sarcoplasmic reticulum and myofibrils. {ECO:0000269|PubMed:12527750}. |
P16401 | H1-5 | T4 | ochoa | Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3) | Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Also acts as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}. |
P16402 | H1-3 | T4 | ochoa | Histone H1.3 (Histone H1c) (Histone H1s-2) | Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Also acts as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}. |
P16403 | H1-2 | T4 | ochoa | Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1) | Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Also acts as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}. |
P20591 | MX1 | S4 | ochoa | Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78) (IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed] | Interferon-induced dynamin-like GTPase with antiviral activity against a wide range of RNA viruses and some DNA viruses. Its target viruses include negative-stranded RNA viruses and HBV through binding and inactivation of their ribonucleocapsid. May also antagonize reoviridae and asfarviridae replication. Inhibits thogoto virus (THOV) replication by preventing the nuclear import of viral nucleocapsids. Inhibits La Crosse virus (LACV) replication by sequestering viral nucleoprotein in perinuclear complexes, preventing genome amplification, budding, and egress. Inhibits influenza A virus (IAV) replication by decreasing or delaying NP synthesis and by blocking endocytic traffic of incoming virus particles. Enhances ER stress-mediated cell death after influenza virus infection. May regulate the calcium channel activity of TRPCs. {ECO:0000269|PubMed:11880649, ECO:0000269|PubMed:14687945, ECO:0000269|PubMed:14752052, ECO:0000269|PubMed:15047845, ECO:0000269|PubMed:15355513, ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:16202617, ECO:0000269|PubMed:16413306, ECO:0000269|PubMed:17374778, ECO:0000269|PubMed:18668195, ECO:0000269|PubMed:19109387, ECO:0000269|PubMed:21900240, ECO:0000269|PubMed:21992152}. |
P35659 | DEK | S4 | ochoa | Protein DEK | Involved in chromatin organization. {ECO:0000269|PubMed:17524367}. |
P35713 | SOX18 | S4 | ochoa | Transcription factor SOX-18 | Transcriptional activator that binds to the consensus sequence 5'-AACAAAG-3' in the promoter of target genes and plays an essential role in embryonic cardiovascular development and lymphangiogenesis. Activates transcription of PROX1 and other genes coding for lymphatic endothelial markers. Plays an essential role in triggering the differentiation of lymph vessels, but is not required for the maintenance of differentiated lymphatic endothelial cells. Plays an important role in postnatal angiogenesis, where it is functionally redundant with SOX17. Interaction with MEF2C enhances transcriptional activation. Besides, required for normal hair development. {ECO:0000250|UniProtKB:P43680}. |
P43007 | SLC1A4 | S4 | ochoa | Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1) (ASCT-1) (Solute carrier family 1 member 4) | Sodium-dependent neutral amino-acid transporter that mediates transport of alanine, serine, cysteine, proline, hydroxyproline and threonine. {ECO:0000269|PubMed:14502423, ECO:0000269|PubMed:26041762, ECO:0000269|PubMed:8101838, ECO:0000269|PubMed:8340364}. |
P49366 | DHPS | S4 | ochoa | Deoxyhypusine synthase (DHS) (EC 2.5.1.46) | Catalyzes the NAD-dependent oxidative cleavage of spermidine and the subsequent transfer of the butylamine moiety of spermidine to the epsilon-amino group of a critical lysine residue of the eIF-5A precursor protein to form the intermediate deoxyhypusine residue (PubMed:30661771). This is the first step of the post-translational modification of that lysine into an unusual amino acid residue named hypusine. Hypusination is unique to mature eIF-5A factor and is essential for its function. {ECO:0000269|PubMed:30661771}. |
P58012 | FOXL2 | S4 | psp | Forkhead box protein L2 | Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans-differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Participates in SMAD3-dependent transcription of FST via the intronic SMAD-binding element (By similarity). Is a transcriptional repressor of STAR. Activates SIRT1 transcription under cellular stress conditions. Activates transcription of OSR2. {ECO:0000250, ECO:0000269|PubMed:16153597, ECO:0000269|PubMed:19010791, ECO:0000269|PubMed:19429596, ECO:0000269|PubMed:19744555}. |
P58012 | FOXL2 | Y5 | psp | Forkhead box protein L2 | Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans-differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Participates in SMAD3-dependent transcription of FST via the intronic SMAD-binding element (By similarity). Is a transcriptional repressor of STAR. Activates SIRT1 transcription under cellular stress conditions. Activates transcription of OSR2. {ECO:0000250, ECO:0000269|PubMed:16153597, ECO:0000269|PubMed:19010791, ECO:0000269|PubMed:19429596, ECO:0000269|PubMed:19744555}. |
P69905 | HBA1; | S4 | ochoa | Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain) [Cleaved into: Hemopressin] | Involved in oxygen transport from the lung to the various peripheral tissues.; FUNCTION: [Hemopressin]: Hemopressin acts as an antagonist peptide of the cannabinoid receptor CNR1 (PubMed:18077343). Hemopressin-binding efficiently blocks cannabinoid receptor CNR1 and subsequent signaling (PubMed:18077343). {ECO:0000269|PubMed:18077343}. |
Q02539 | H1-1 | T4 | ochoa | Histone H1.1 (Histone H1a) | Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Also acts as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}. |
Q06330 | RBPJ | T4 | ochoa | Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa) (RBP-J) (RBP-JK) (Renal carcinoma antigen NY-REN-30) | Transcriptional regulator that plays a central role in Notch signaling, a signaling pathway involved in cell-cell communication that regulates a broad spectrum of cell-fate determinations. Acts as a transcriptional repressor when it is not associated with Notch proteins. When associated with some NICD product of Notch proteins (Notch intracellular domain), it acts as a transcriptional activator that activates transcription of Notch target genes. Probably represses or activates transcription via the recruitment of chromatin remodeling complexes containing histone deacetylase or histone acetylase proteins, respectively. Specifically binds to the immunoglobulin kappa-type J segment recombination signal sequence. Binds specifically to methylated DNA (PubMed:21991380). Binds to the oxygen responsive element of COX4I2 and activates its transcription under hypoxia conditions (4% oxygen) (PubMed:23303788). Negatively regulates the phagocyte oxidative burst in response to bacterial infection by repressing transcription of NADPH oxidase subunits (By similarity). {ECO:0000250|UniProtKB:P31266, ECO:0000269|PubMed:21991380, ECO:0000269|PubMed:23303788}. |
Q08AG7 | MZT1 | S3 | ochoa | Mitotic-spindle organizing protein 1 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1) | Required for the recruitment and the assembly of the gamma-tubulin ring complex (gTuRC) at the centrosome (PubMed:20360068, PubMed:38609661, PubMed:39321809). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplication and spindle formation (PubMed:38609661, PubMed:39321809). {ECO:0000269|PubMed:20360068, ECO:0000269|PubMed:38609661, ECO:0000269|PubMed:39321809}. |
Q08AG7 | MZT1 | S4 | ochoa | Mitotic-spindle organizing protein 1 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1) | Required for the recruitment and the assembly of the gamma-tubulin ring complex (gTuRC) at the centrosome (PubMed:20360068, PubMed:38609661, PubMed:39321809). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplication and spindle formation (PubMed:38609661, PubMed:39321809). {ECO:0000269|PubMed:20360068, ECO:0000269|PubMed:38609661, ECO:0000269|PubMed:39321809}. |
Q08AG7 | MZT1 | S5 | ochoa | Mitotic-spindle organizing protein 1 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1) | Required for the recruitment and the assembly of the gamma-tubulin ring complex (gTuRC) at the centrosome (PubMed:20360068, PubMed:38609661, PubMed:39321809). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplication and spindle formation (PubMed:38609661, PubMed:39321809). {ECO:0000269|PubMed:20360068, ECO:0000269|PubMed:38609661, ECO:0000269|PubMed:39321809}. |
Q13263 | TRIM28 | S4 | ochoa | Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28) | Nuclear corepressor for KRAB domain-containing zinc finger proteins (KRAB-ZFPs). Mediates gene silencing by recruiting CHD3, a subunit of the nucleosome remodeling and deacetylation (NuRD) complex, and SETDB1 (which specifically methylates histone H3 at 'Lys-9' (H3K9me)) to the promoter regions of KRAB target genes. Enhances transcriptional repression by coordinating the increase in H3K9me, the decrease in histone H3 'Lys-9 and 'Lys-14' acetylation (H3K9ac and H3K14ac, respectively) and the disposition of HP1 proteins to silence gene expression. Recruitment of SETDB1 induces heterochromatinization. May play a role as a coactivator for CEBPB and NR3C1 in the transcriptional activation of ORM1. Also a corepressor for ERBB4. Inhibits E2F1 activity by stimulating E2F1-HDAC1 complex formation and inhibiting E2F1 acetylation. May serve as a partial backup to prevent E2F1-mediated apoptosis in the absence of RB1. Important regulator of CDKN1A/p21(CIP1). Has E3 SUMO-protein ligase activity toward itself via its PHD-type zinc finger. Also specifically sumoylates IRF7, thereby inhibiting its transactivation activity. Ubiquitinates p53/TP53 leading to its proteasomal degradation; the function is enhanced by MAGEC2 and MAGEA2, and possibly MAGEA3 and MAGEA6. Mediates the nuclear localization of KOX1, ZNF268 and ZNF300 transcription factors. In association with isoform 2 of ZFP90, is required for the transcriptional repressor activity of FOXP3 and the suppressive function of regulatory T-cells (Treg) (PubMed:23543754). Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). In ESCs, in collaboration with SETDB1, is also required for H3K9me3 and silencing of endogenous and introduced retroviruses in a DNA-methylation independent-pathway (By similarity). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (PubMed:27029610). {ECO:0000250|UniProtKB:Q62318, ECO:0000269|PubMed:10347202, ECO:0000269|PubMed:11959841, ECO:0000269|PubMed:15882967, ECO:0000269|PubMed:16107876, ECO:0000269|PubMed:16862143, ECO:0000269|PubMed:17079232, ECO:0000269|PubMed:17178852, ECO:0000269|PubMed:17704056, ECO:0000269|PubMed:17942393, ECO:0000269|PubMed:18060868, ECO:0000269|PubMed:18082607, ECO:0000269|PubMed:20424263, ECO:0000269|PubMed:20858735, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:21940674, ECO:0000269|PubMed:23543754, ECO:0000269|PubMed:23665872, ECO:0000269|PubMed:24623306, ECO:0000269|PubMed:27029610, ECO:0000269|PubMed:8769649, ECO:0000269|PubMed:9016654}.; FUNCTION: (Microbial infection) Plays a critical role in the shutdown of lytic gene expression during the early stage of herpes virus 8 primary infection. This inhibition is mediated through interaction with herpes virus 8 protein LANA1. {ECO:0000269|PubMed:24741090}. |
Q13614 | MTMR2 | S4 | ochoa | Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2 (EC 3.1.3.95) (Myotubularin-related protein 2) (Phosphatidylinositol-3-phosphate phosphatase) | Lipid phosphatase that specifically dephosphorylates the D-3 position of phosphatidylinositol 3-phosphate and phosphatidylinositol 3,5-bisphosphate, generating phosphatidylinositol and phosphatidylinositol 5-phosphate (PubMed:11733541, PubMed:12668758, PubMed:14690594, PubMed:21372139). Regulates the level of these phosphoinositides critical for various biological processes including autophagy initiation and autophagosome maturation (PubMed:35580604). {ECO:0000269|PubMed:11733541, ECO:0000269|PubMed:12668758, ECO:0000269|PubMed:14690594, ECO:0000269|PubMed:21372139, ECO:0000269|PubMed:35580604}. |
Q14151 | SAFB2 | T4 | ochoa | Scaffold attachment factor B2 (SAF-B2) | Binds to scaffold/matrix attachment region (S/MAR) DNA. Can function as an estrogen receptor corepressor and can also inhibit cell proliferation. |
Q15172 | PPP2R5A | S4 | ochoa | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) | The B regulatory subunit might modulate substrate selectivity and catalytic activity, and might also direct the localization of the catalytic enzyme to a particular subcellular compartment. |
Q5T4S7 | UBR4 | T3 | ochoa | E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) | E3 ubiquitin-protein ligase involved in different protein quality control pathways in the cytoplasm (PubMed:25582440, PubMed:29033132, PubMed:34893540, PubMed:37891180, PubMed:38030679, PubMed:38182926, PubMed:38297121). Component of the N-end rule pathway: ubiquitinates proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their degradation (PubMed:34893540, PubMed:37891180, PubMed:38030679). Recognizes both type-1 and type-2 N-degrons, containing positively charged amino acids (Arg, Lys and His) and bulky and hydrophobic amino acids, respectively (PubMed:38030679). Does not ubiquitinate proteins that are acetylated at the N-terminus (PubMed:37891180). Together with UBR5, part of a cytoplasm protein quality control pathway that prevents protein aggregation by catalyzing assembly of heterotypic 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on aggregated proteins, leading to substrate recognition by the segregase p97/VCP and degradation by the proteasome: UBR4 probably synthesizes mixed chains containing multiple linkages, while UBR5 is likely branching multiple 'Lys-48'-linked chains of substrates initially modified (PubMed:29033132). Together with KCMF1, part of a protein quality control pathway that catalyzes ubiquitination and degradation of proteins that have been oxidized in response to reactive oxygen species (ROS): recognizes proteins with an Arg-CysO3(H) degron at the N-terminus, and mediates assembly of heterotypic 'Lys-63'-/'Lys-27'-linked branched ubiquitin chains on oxidized proteins, leading to their degradation by autophagy (PubMed:34893540). Catalytic component of the SIFI complex, a multiprotein complex required to inhibit the mitochondrial stress response after a specific stress event has been resolved: ubiquitinates and degrades (1) components of the HRI-mediated signaling of the integrated stress response, such as DELE1 and EIF2AK1/HRI, as well as (2) unimported mitochondrial precursors (PubMed:38297121). Within the SIFI complex, UBR4 initiates ubiquitin chain that are further elongated or branched by KCMF1 (PubMed:38297121). Mediates ubiquitination of ACLY, leading to its subsequent degradation (PubMed:23932781). Together with clathrin, forms meshwork structures involved in membrane morphogenesis and cytoskeletal organization (PubMed:16214886). {ECO:0000269|PubMed:16214886, ECO:0000269|PubMed:23932781, ECO:0000269|PubMed:25582440, ECO:0000269|PubMed:29033132, ECO:0000269|PubMed:34893540, ECO:0000269|PubMed:37891180, ECO:0000269|PubMed:38030679, ECO:0000269|PubMed:38182926, ECO:0000269|PubMed:38297121}. |
Q5T4S7 | UBR4 | S4 | ochoa | E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) | E3 ubiquitin-protein ligase involved in different protein quality control pathways in the cytoplasm (PubMed:25582440, PubMed:29033132, PubMed:34893540, PubMed:37891180, PubMed:38030679, PubMed:38182926, PubMed:38297121). Component of the N-end rule pathway: ubiquitinates proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their degradation (PubMed:34893540, PubMed:37891180, PubMed:38030679). Recognizes both type-1 and type-2 N-degrons, containing positively charged amino acids (Arg, Lys and His) and bulky and hydrophobic amino acids, respectively (PubMed:38030679). Does not ubiquitinate proteins that are acetylated at the N-terminus (PubMed:37891180). Together with UBR5, part of a cytoplasm protein quality control pathway that prevents protein aggregation by catalyzing assembly of heterotypic 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on aggregated proteins, leading to substrate recognition by the segregase p97/VCP and degradation by the proteasome: UBR4 probably synthesizes mixed chains containing multiple linkages, while UBR5 is likely branching multiple 'Lys-48'-linked chains of substrates initially modified (PubMed:29033132). Together with KCMF1, part of a protein quality control pathway that catalyzes ubiquitination and degradation of proteins that have been oxidized in response to reactive oxygen species (ROS): recognizes proteins with an Arg-CysO3(H) degron at the N-terminus, and mediates assembly of heterotypic 'Lys-63'-/'Lys-27'-linked branched ubiquitin chains on oxidized proteins, leading to their degradation by autophagy (PubMed:34893540). Catalytic component of the SIFI complex, a multiprotein complex required to inhibit the mitochondrial stress response after a specific stress event has been resolved: ubiquitinates and degrades (1) components of the HRI-mediated signaling of the integrated stress response, such as DELE1 and EIF2AK1/HRI, as well as (2) unimported mitochondrial precursors (PubMed:38297121). Within the SIFI complex, UBR4 initiates ubiquitin chain that are further elongated or branched by KCMF1 (PubMed:38297121). Mediates ubiquitination of ACLY, leading to its subsequent degradation (PubMed:23932781). Together with clathrin, forms meshwork structures involved in membrane morphogenesis and cytoskeletal organization (PubMed:16214886). {ECO:0000269|PubMed:16214886, ECO:0000269|PubMed:23932781, ECO:0000269|PubMed:25582440, ECO:0000269|PubMed:29033132, ECO:0000269|PubMed:34893540, ECO:0000269|PubMed:37891180, ECO:0000269|PubMed:38030679, ECO:0000269|PubMed:38182926, ECO:0000269|PubMed:38297121}. |
Q5VV17 | OTUD1 | Y4 | ochoa | OTU domain-containing protein 1 (EC 3.4.19.12) (DUBA-7) | Deubiquitinating enzyme that specifically hydrolyzes 'Lys-63'-linked polyubiquitin to monoubiquitin (PubMed:23827681). Required for the stability and translation of a subset mRNAs with a high abundance of rare codons by mediating deubiquitination of 40S ribosomal protein RPS10/eS10, thereby antagonizing ZNF598-mediated 40S ubiquitination (PubMed:36445135). The abundance of rare codons in mRNAs can limit the translation rate and can lead to ribosome collisions that trigger activation of ribosome quality control (RQC) pathway by ZNF598 (PubMed:36445135). OTUD1-mediated deubiquitination prevents activation of the RQC and subsequent dissociation of ribosomes and stimulates formation of polysomes and translation (PubMed:36445135). {ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:36445135}. |
Q7KZF4 | SND1 | S4 | ochoa | Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator) | Endonuclease that mediates miRNA decay of both protein-free and AGO2-loaded miRNAs (PubMed:18453631, PubMed:28546213). As part of its function in miRNA decay, regulates mRNAs involved in G1-to-S phase transition (PubMed:28546213). Functions as a bridging factor between STAT6 and the basal transcription factor (PubMed:12234934). Plays a role in PIM1 regulation of MYB activity (PubMed:9809063). Functions as a transcriptional coactivator for STAT5 (By similarity). {ECO:0000250|UniProtKB:Q78PY7, ECO:0000269|PubMed:12234934, ECO:0000269|PubMed:18453631, ECO:0000269|PubMed:28546213, ECO:0000269|PubMed:9809063}.; FUNCTION: (Microbial infection) Functions as a transcriptional coactivator for the Epstein-Barr virus nuclear antigen 2 (EBNA2). {ECO:0000269|PubMed:7651391}.; FUNCTION: (Microbial infection) Promotes SARS-CoV-2 RNA synthesis by binding to negative-sense RNA and the viral protein nsp9. {ECO:0000269|PubMed:37794589}. |
Q86TI2 | DPP9 | T4 | ochoa | Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) | Dipeptidyl peptidase that cleaves off N-terminal dipeptides from proteins having a Pro or Ala residue at position 2 (PubMed:12662155, PubMed:16475979, PubMed:19667070, PubMed:29382749, PubMed:30291141, PubMed:33731929, PubMed:36112693). Acts as a key inhibitor of caspase-1-dependent monocyte and macrophage pyroptosis in resting cells by preventing activation of NLRP1 and CARD8 (PubMed:27820798, PubMed:29967349, PubMed:30291141, PubMed:31525884, PubMed:32796818, PubMed:36112693, PubMed:36357533). Sequesters the cleaved C-terminal part of NLRP1 and CARD8, which respectively constitute the active part of the NLRP1 and CARD8 inflammasomes, in a ternary complex, thereby preventing their oligomerization and activation (PubMed:33731929, PubMed:33731932, PubMed:34019797). The dipeptidyl peptidase activity is required to suppress NLRP1 and CARD8; however, neither NLRP1 nor CARD8 are bona fide substrates of DPP9, suggesting the existence of substrate(s) required for NLRP1 and CARD8 inhibition (PubMed:33731929). {ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:16475979, ECO:0000269|PubMed:19667070, ECO:0000269|PubMed:27820798, ECO:0000269|PubMed:29382749, ECO:0000269|PubMed:29967349, ECO:0000269|PubMed:30291141, ECO:0000269|PubMed:31525884, ECO:0000269|PubMed:32796818, ECO:0000269|PubMed:33731929, ECO:0000269|PubMed:33731932, ECO:0000269|PubMed:34019797, ECO:0000269|PubMed:36112693, ECO:0000269|PubMed:36357533}. |
Q86VQ6 | TXNRD3 | S4 | ochoa | Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase 3 intronic transcript 1) (Thioredoxin reductase 3 neighbor gene) (Thioredoxin reductase TR2) | Displays thioredoxin reductase, glutaredoxin and glutathione reductase activities. Catalyzes disulfide bond isomerization. Promotes disulfide bond formation between GPX4 and various sperm proteins and may play a role in sperm maturation by promoting formation of sperm structural components (By similarity). {ECO:0000250|UniProtKB:Q99MD6}. |
Q8N697 | SLC15A4 | S4 | ochoa | Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1) | Proton-coupled amino-acid transporter that mediates the transmembrane transport of L-histidine and some di- and tripeptides from inside the lysosome to the cytosol, and plays a key role in innate immune response (PubMed:16289537, PubMed:25238095, PubMed:29224352). Able to transport a variety of di- and tripeptides, including carnosine and some peptidoglycans (PubMed:29224352, PubMed:31073693). Transporter activity is pH-dependent and maximized in the acidic lysosomal environment (By similarity). Involved in the detection of microbial pathogens by toll-like receptors (TLRs) and NOD-like receptors (NLRs), probably by mediating transport of bacterial peptidoglycans across the endolysosomal membrane: catalyzes the transport of certain bacterial peptidoglycans, such as muramyl dipeptide (MDP), the NOD2 ligand, and L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate (tri-DAP), the NOD1 ligand (PubMed:25238095, PubMed:29224352). Required for TLR7, TLR8 and TLR9-mediated type I interferon (IFN-I) productions in plasmacytoid dendritic cells (pDCs) (PubMed:25238095). Independently of its transporter activity, also promotes the recruitment of innate immune adapter TASL to endolysosome downstream of TLR7, TLR8 and TLR9: TASL recruitment leads to the specific recruitment and activation of IRF5 (PubMed:32433612). Required for isotype class switch recombination to IgG2c isotype in response to TLR9 stimulation (By similarity). Required for mast cell secretory-granule homeostasis by limiting mast cell functions and inflammatory responses (By similarity). {ECO:0000250|UniProtKB:O09014, ECO:0000250|UniProtKB:Q91W98, ECO:0000269|PubMed:16289537, ECO:0000269|PubMed:25238095, ECO:0000269|PubMed:29224352, ECO:0000269|PubMed:31073693, ECO:0000269|PubMed:32433612}. |
Q8ND24 | RNF214 | S4 | ochoa | RING finger protein 214 | None |
Q92945 | KHSRP | Y4 | ochoa | Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75) | Binds to the dendritic targeting element and may play a role in mRNA trafficking (By similarity). Part of a ternary complex that binds to the downstream control sequence (DCS) of the pre-mRNA. Mediates exon inclusion in transcripts that are subject to tissue-specific alternative splicing. May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their 3'-UTR, possibly by recruiting degradation machinery to ARE-containing mRNAs. {ECO:0000250, ECO:0000269|PubMed:11003644, ECO:0000269|PubMed:8940189, ECO:0000269|PubMed:9136930}. |
Q96B49 | TOMM6 | S4 | ochoa | Mitochondrial import receptor subunit TOM6 homolog (Overexpressed breast tumor protein) (Translocase of outer membrane 6 kDa subunit homolog) | None |
Q96C90 | PPP1R14B | S4 | ochoa | Protein phosphatase 1 regulatory subunit 14B (Phospholipase C-beta-3 neighbouring gene protein) | Inhibitor of PPP1CA. Has over 50-fold higher inhibitory activity when phosphorylated (By similarity). {ECO:0000250}. |
Q96NT5 | SLC46A1 | S4 | ochoa | Proton-coupled folate transporter (HsPCFT) (hPCFT) (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1) | Proton-coupled folate symporter that mediates folate absorption using an H(+) gradient as a driving force (PubMed:17129779, PubMed:17446347, PubMed:17475902, PubMed:19389703, PubMed:19762432, PubMed:25504888, PubMed:29344585, PubMed:30858177, PubMed:31494288, PubMed:31792273, PubMed:32893190, PubMed:34619546). Involved in the intestinal absorption of folates at the brush-border membrane of the proximal jejunum, and the transport from blood to cerebrospinal fluid across the choroid plexus (PubMed:17129779, PubMed:17446347, PubMed:17475902, PubMed:19389703, PubMed:25504888, PubMed:29344585, PubMed:30858177, PubMed:31494288, PubMed:32893190). Functions at acidic pH via alternate outward- and inward-open conformation states (PubMed:32893190, PubMed:34040256). Protonation of residues in the outward open state primes the protein for transport (PubMed:34040256). Binding of folate promotes breaking of salt bridge network and subsequent closure of the extracellular gate, leading to the inward-open state and release of protons and folate (PubMed:34040256). Also able to transport antifolate drugs, such as methotrexate and pemetrexed, which are established treatments for cancer and autoimmune diseases (PubMed:18524888, PubMed:19762432, PubMed:22345511, PubMed:25608532, PubMed:28802835, PubMed:29326243, PubMed:34040256, PubMed:34619546). Involved in FOLR1-mediated endocytosis by serving as a route of export of folates from acidified endosomes (PubMed:19074442). Also acts as a lower-affinity, pH-independent heme carrier protein and constitutes the main importer of heme in the intestine (PubMed:17156779). Imports heme in the retina and retinal pigment epithelium, in neurons of the hippocampus, in hepatocytes and in the renal epithelial cells (PubMed:32621820). Hence, participates in the trafficking of heme and increases intracellular iron content (PubMed:32621820). {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17156779, ECO:0000269|PubMed:17446347, ECO:0000269|PubMed:17475902, ECO:0000269|PubMed:18524888, ECO:0000269|PubMed:19074442, ECO:0000269|PubMed:19389703, ECO:0000269|PubMed:19762432, ECO:0000269|PubMed:22345511, ECO:0000269|PubMed:25504888, ECO:0000269|PubMed:25608532, ECO:0000269|PubMed:28802835, ECO:0000269|PubMed:29326243, ECO:0000269|PubMed:29344585, ECO:0000269|PubMed:30858177, ECO:0000269|PubMed:31494288, ECO:0000269|PubMed:31792273, ECO:0000269|PubMed:32621820, ECO:0000269|PubMed:32893190, ECO:0000269|PubMed:34040256, ECO:0000269|PubMed:34619546}.; FUNCTION: [Isoform 2]: Inactive isoform which is not able to mediate proton-coupled folate transport. {ECO:0000269|PubMed:17129779}. |
Q9H6S3 | EPS8L2 | S4 | ochoa | Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2) | Stimulates guanine exchange activity of SOS1. May play a role in membrane ruffling and remodeling of the actin cytoskeleton. In the cochlea, is required for stereocilia maintenance in adult hair cells (By similarity). {ECO:0000250|UniProtKB:Q99K30, ECO:0000269|PubMed:14565974}. |
Q9NUP7 | TRMT13 | S4 | ochoa | tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76) | tRNA methylase which 2'-O-methylates cytidine(4) in tRNA(Pro) and tRNA(Gly)(GCC), and adenosine(4) in tRNA(His). {ECO:0000250|UniProtKB:Q12383}. |
Q9UBT7 | CTNNAL1 | S4 | ochoa | Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1) | May modulate the Rho pathway signaling by providing a scaffold for the Lbc Rho guanine nucleotide exchange factor (ARHGEF1). |
Q9UMX0 | UBQLN1 | S4 | ochoa | Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1) | Plays an important role in the regulation of different protein degradation mechanisms and pathways including ubiquitin-proteasome system (UPS), autophagy and endoplasmic reticulum-associated protein degradation (ERAD) pathway. Mediates the proteasomal targeting of misfolded or accumulated proteins for degradation by binding (via UBA domain) to their polyubiquitin chains and by interacting (via ubiquitin-like domain) with the subunits of the proteasome (PubMed:15147878). Plays a role in the ERAD pathway via its interaction with ER-localized proteins UBXN4, VCP and HERPUD1 and may form a link between the polyubiquitinated ERAD substrates and the proteasome (PubMed:18307982, PubMed:19822669). Involved in the regulation of macroautophagy and autophagosome formation; required for maturation of autophagy-related protein LC3 from the cytosolic form LC3-I to the membrane-bound form LC3-II and may assist in the maturation of autophagosomes to autolysosomes by mediating autophagosome-lysosome fusion (PubMed:19148225, PubMed:20529957, PubMed:23459205). Negatively regulates the TICAM1/TRIF-dependent toll-like receptor signaling pathway by decreasing the abundance of TICAM1 via the autophagic pathway (PubMed:21695056). Promotes the ubiquitination and lysosomal degradation of ORAI1, consequently down-regulating the ORAI1-mediated Ca2+ mobilization (PubMed:23307288). Suppresses the maturation and proteasomal degradation of amyloid beta A4 protein (A4) by stimulating the lysine 63 (K63)-linked polyubiquitination. Delays the maturation of A4 by sequestering it in the Golgi apparatus and preventing its transport to the cell surface for subsequent processing (By similarity). Ubiquitinates BCL2L10 and thereby stabilizes protein abundance (PubMed:22233804). {ECO:0000250|UniProtKB:Q9JJP9, ECO:0000269|PubMed:18307982, ECO:0000269|PubMed:19148225, ECO:0000269|PubMed:19822669, ECO:0000269|PubMed:20529957, ECO:0000269|PubMed:21695056, ECO:0000269|PubMed:22233804, ECO:0000269|PubMed:23307288, ECO:0000269|PubMed:23459205, ECO:0000303|PubMed:15147878}.; FUNCTION: [Isoform 1]: Plays a role in unfolded protein response (UPR) by attenuating the induction of UPR-inducible genes, DDTI3/CHOP, HSPA5 and PDIA2 during ER stress (PubMed:18953672). Plays a key role in the regulation of the levels of PSEN1 by targeting its accumulation to aggresomes which may then be removed from cells by autophagocytosis (PubMed:21143716). {ECO:0000269|PubMed:18953672, ECO:0000269|PubMed:21143716}.; FUNCTION: [Isoform 2]: Plays a role in unfolded protein response (UPR) by attenuating the induction of UPR-inducible genes, DDTI3/CHOP, HSPA5 and PDIA2 during ER stress. {ECO:0000269|PubMed:18953672}.; FUNCTION: [Isoform 3]: Plays a role in unfolded protein response (UPR) by attenuating the induction of UPR-inducible genes, DDTI3/CHOP, HSPA5 and PDIA2 during ER stress (PubMed:18953672). Plays a key role in the regulation of the levels of PSEN1 by targeting its accumulation to aggresomes which may then be removed from cells by autophagocytosis (PubMed:21143716). {ECO:0000269|PubMed:18953672, ECO:0000269|PubMed:21143716}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 7.029377e-12 | 11.153 |
R-HSA-140342 | Apoptosis induced DNA fragmentation | 2.845330e-10 | 9.546 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 6.926076e-10 | 9.160 |
R-HSA-75153 | Apoptotic execution phase | 3.253065e-07 | 6.488 |
R-HSA-2559583 | Cellular Senescence | 8.126065e-07 | 6.090 |
R-HSA-109581 | Apoptosis | 1.051845e-04 | 3.978 |
R-HSA-427975 | Proton/oligopeptide cotransporters | 2.097103e-04 | 3.678 |
R-HSA-9959399 | SLC-mediated transport of oligopeptides | 3.265904e-04 | 3.486 |
R-HSA-2262752 | Cellular responses to stress | 2.706334e-04 | 3.568 |
R-HSA-5357801 | Programmed Cell Death | 2.945214e-04 | 3.531 |
R-HSA-8953897 | Cellular responses to stimuli | 6.748275e-04 | 3.171 |
R-HSA-9661070 | Defective translocation of RB1 mutants to the nucleus | 2.604892e-03 | 2.584 |
R-HSA-69200 | Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 ... | 1.553032e-02 | 1.809 |
R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | 3.587162e-02 | 1.445 |
R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | 3.587162e-02 | 1.445 |
R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | 3.587162e-02 | 1.445 |
R-HSA-5339716 | Signaling by GSK3beta mutants | 3.838525e-02 | 1.416 |
R-HSA-2197563 | NOTCH2 intracellular domain regulates transcription | 4.089249e-02 | 1.388 |
R-HSA-4839743 | Signaling by CTNNB1 phospho-site mutants | 4.089249e-02 | 1.388 |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | 4.089249e-02 | 1.388 |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | 4.089249e-02 | 1.388 |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | 4.089249e-02 | 1.388 |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | 4.089249e-02 | 1.388 |
R-HSA-9659787 | Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 4.339334e-02 | 1.363 |
R-HSA-9661069 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 4.339334e-02 | 1.363 |
R-HSA-196299 | Beta-catenin phosphorylation cascade | 4.837596e-02 | 1.315 |
R-HSA-450604 | KSRP (KHSRP) binds and destabilizes mRNA | 5.085777e-02 | 1.294 |
R-HSA-9687136 | Aberrant regulation of mitotic exit in cancer due to RB1 defects | 5.085777e-02 | 1.294 |
R-HSA-350054 | Notch-HLH transcription pathway | 7.048602e-02 | 1.152 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 1.117367e-02 | 1.952 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 8.255187e-02 | 1.083 |
R-HSA-171306 | Packaging Of Telomere Ends | 8.255187e-02 | 1.083 |
R-HSA-5334118 | DNA methylation | 8.733527e-02 | 1.059 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 8.971784e-02 | 1.047 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 1.776801e-02 | 1.750 |
R-HSA-212300 | PRC2 methylates histones and DNA | 1.062266e-01 | 0.974 |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | 8.971784e-02 | 1.047 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 8.857494e-03 | 2.053 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 5.175177e-02 | 1.286 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 5.175177e-02 | 1.286 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 6.561644e-02 | 1.183 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 5.175177e-02 | 1.286 |
R-HSA-389513 | Co-inhibition by CTLA4 | 6.317231e-02 | 1.199 |
R-HSA-3214815 | HDACs deacetylate histones | 1.518006e-01 | 0.819 |
R-HSA-9842860 | Regulation of endogenous retroelements | 3.522355e-02 | 1.453 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 1.155286e-01 | 0.937 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 1.606392e-01 | 0.794 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated gene... | 1.178393e-01 | 0.929 |
R-HSA-8941856 | RUNX3 regulates NOTCH signaling | 4.089249e-02 | 1.388 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 1.819675e-02 | 1.740 |
R-HSA-9860276 | SLC15A4:TASL-dependent IRF5 activation | 2.065457e-02 | 1.685 |
R-HSA-204626 | Hypusine synthesis from eIF5A-lysine | 3.082510e-02 | 1.511 |
R-HSA-113501 | Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 3.838525e-02 | 1.416 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 1.383720e-01 | 0.859 |
R-HSA-1221632 | Meiotic synapsis | 1.473472e-01 | 0.832 |
R-HSA-9843970 | Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | 1.015399e-01 | 0.993 |
R-HSA-1483248 | Synthesis of PIPs at the ER membrane | 3.587162e-02 | 1.445 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 9.446477e-02 | 1.025 |
R-HSA-427359 | SIRT1 negatively regulates rRNA expression | 1.085610e-01 | 0.964 |
R-HSA-212165 | Epigenetic regulation of gene expression | 1.210173e-02 | 1.917 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 1.628347e-01 | 0.788 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 1.628347e-01 | 0.788 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 1.628347e-01 | 0.788 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 1.628347e-01 | 0.788 |
R-HSA-9012852 | Signaling by NOTCH3 | 1.518006e-01 | 0.819 |
R-HSA-4839744 | Signaling by APC mutants | 3.587162e-02 | 1.445 |
R-HSA-4839735 | Signaling by AXIN mutants | 3.838525e-02 | 1.416 |
R-HSA-4839748 | Signaling by AMER1 mutants | 3.838525e-02 | 1.416 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 6.072195e-02 | 1.217 |
R-HSA-73728 | RNA Polymerase I Promoter Opening | 8.255187e-02 | 1.083 |
R-HSA-4791275 | Signaling by WNT in cancer | 9.446477e-02 | 1.025 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 1.155286e-01 | 0.937 |
R-HSA-9821002 | Chromatin modifications during the maternal to zygotic transition (MZT) | 1.178393e-01 | 0.929 |
R-HSA-774815 | Nucleosome assembly | 1.293046e-01 | 0.888 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 1.293046e-01 | 0.888 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 1.451120e-01 | 0.838 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 1.473472e-01 | 0.832 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 1.628347e-01 | 0.788 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 7.418540e-02 | 1.130 |
R-HSA-447043 | Neurofascin interactions | 2.320693e-02 | 1.634 |
R-HSA-1980145 | Signaling by NOTCH2 | 1.015399e-01 | 0.993 |
R-HSA-9927020 | Heme assimilation | 5.333325e-02 | 1.273 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 8.255187e-02 | 1.083 |
R-HSA-912446 | Meiotic recombination | 1.428711e-01 | 0.845 |
R-HSA-5357786 | TNFR1-induced proapoptotic signaling | 6.561644e-02 | 1.183 |
R-HSA-9710421 | Defective pyroptosis | 1.247360e-01 | 0.904 |
R-HSA-157118 | Signaling by NOTCH | 1.473245e-01 | 0.832 |
R-HSA-68877 | Mitotic Prometaphase | 1.057084e-01 | 0.976 |
R-HSA-9824272 | Somitogenesis | 1.293046e-01 | 0.888 |
R-HSA-1660516 | Synthesis of PIPs at the early endosome membrane | 7.774399e-02 | 1.109 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 1.361139e-01 | 0.866 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 1.628347e-01 | 0.788 |
R-HSA-1660517 | Synthesis of PIPs at the late endosome membrane | 5.580243e-02 | 1.253 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 8.255187e-02 | 1.083 |
R-HSA-68875 | Mitotic Prophase | 4.787344e-02 | 1.320 |
R-HSA-447038 | NrCAM interactions | 1.809571e-02 | 1.742 |
R-HSA-210744 | Regulation of gene expression in late stage (branching morphogenesis) pancreatic... | 5.085777e-02 | 1.294 |
R-HSA-1237044 | Erythrocytes take up carbon dioxide and release oxygen | 6.072195e-02 | 1.217 |
R-HSA-110331 | Cleavage of the damaged purine | 1.085610e-01 | 0.964 |
R-HSA-1480926 | O2/CO2 exchange in erythrocytes | 6.072195e-02 | 1.217 |
R-HSA-73927 | Depurination | 1.108895e-01 | 0.955 |
R-HSA-8940973 | RUNX2 regulates osteoblast differentiation | 8.494662e-02 | 1.071 |
R-HSA-447041 | CHL1 interactions | 2.575279e-02 | 1.589 |
R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected ... | 9.446477e-02 | 1.025 |
R-HSA-68886 | M Phase | 2.062366e-02 | 1.686 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 9.682916e-02 | 1.014 |
R-HSA-69231 | Cyclin D associated events in G1 | 1.270233e-01 | 0.896 |
R-HSA-69236 | G1 Phase | 1.270233e-01 | 0.896 |
R-HSA-1247673 | Erythrocytes take up oxygen and release carbon dioxide | 4.089249e-02 | 1.388 |
R-HSA-9821993 | Replacement of protamines by nucleosomes in the male pronucleus | 7.533084e-02 | 1.123 |
R-HSA-5673000 | RAF activation | 1.015399e-01 | 0.993 |
R-HSA-9609690 | HCMV Early Events | 1.082023e-01 | 0.966 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 2.817476e-02 | 1.550 |
R-HSA-8941326 | RUNX2 regulates bone development | 1.062266e-01 | 0.974 |
R-HSA-9764790 | Positive Regulation of CDH1 Gene Transcription | 3.335157e-02 | 1.477 |
R-HSA-380994 | ATF4 activates genes in response to endoplasmic reticulum stress | 8.494662e-02 | 1.071 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 1.618746e-01 | 0.791 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 4.227050e-02 | 1.374 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 1.451120e-01 | 0.838 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 1.540187e-01 | 0.812 |
R-HSA-9707616 | Heme signaling | 1.449871e-02 | 1.839 |
R-HSA-352230 | Amino acid transport across the plasma membrane | 1.606392e-01 | 0.794 |
R-HSA-432142 | Platelet sensitization by LDL | 5.826532e-02 | 1.235 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 1.449871e-02 | 1.839 |
R-HSA-1640170 | Cell Cycle | 1.211038e-01 | 0.917 |
R-HSA-389356 | Co-stimulation by CD28 | 1.361139e-01 | 0.866 |
R-HSA-73929 | Base-Excision Repair, AP Site Formation | 1.495767e-01 | 0.825 |
R-HSA-381042 | PERK regulates gene expression | 1.038862e-01 | 0.983 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 1.776801e-02 | 1.750 |
R-HSA-69278 | Cell Cycle, Mitotic | 6.604157e-02 | 1.180 |
R-HSA-909733 | Interferon alpha/beta signaling | 4.472817e-02 | 1.349 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 1.584380e-01 | 0.800 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 1.628347e-01 | 0.788 |
R-HSA-75893 | TNF signaling | 1.540187e-01 | 0.812 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 1.270233e-01 | 0.896 |
R-HSA-196757 | Metabolism of folate and pterines | 1.085610e-01 | 0.964 |
R-HSA-9609646 | HCMV Infection | 1.563856e-01 | 0.806 |
R-HSA-5205685 | PINK1-PRKN Mediated Mitophagy | 8.494662e-02 | 1.071 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 1.201441e-01 | 0.920 |
R-HSA-9690406 | Transcriptional regulation of testis differentiation | 5.333325e-02 | 1.273 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 8.952124e-02 | 1.048 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 8.952124e-02 | 1.048 |
R-HSA-2559585 | Oncogene Induced Senescence | 1.038862e-01 | 0.983 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 5.043842e-02 | 1.297 |
R-HSA-110329 | Cleavage of the damaged pyrimidine | 1.224430e-01 | 0.912 |
R-HSA-73928 | Depyrimidination | 1.224430e-01 | 0.912 |
R-HSA-9682706 | Replication of the SARS-CoV-1 genome | 4.339334e-02 | 1.363 |
R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected ... | 1.015399e-01 | 0.993 |
R-HSA-9694686 | Replication of the SARS-CoV-2 genome | 5.580243e-02 | 1.253 |
R-HSA-5205647 | Mitophagy | 1.015399e-01 | 0.993 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 7.418540e-02 | 1.130 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 9.751624e-02 | 1.011 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 1.082023e-01 | 0.966 |
R-HSA-913531 | Interferon Signaling | 8.808938e-02 | 1.055 |
R-HSA-9679514 | SARS-CoV-1 Genome Replication and Transcription | 4.588783e-02 | 1.338 |
R-HSA-186712 | Regulation of beta-cell development | 1.606392e-01 | 0.794 |
R-HSA-9694682 | SARS-CoV-2 Genome Replication and Transcription | 6.072195e-02 | 1.217 |
R-HSA-418990 | Adherens junctions interactions | 1.278260e-01 | 0.893 |
R-HSA-421270 | Cell-cell junction organization | 1.572978e-01 | 0.803 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 1.361139e-01 | 0.866 |
R-HSA-425407 | SLC-mediated transmembrane transport | 9.520513e-02 | 1.021 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 1.315802e-01 | 0.881 |
R-HSA-382551 | Transport of small molecules | 1.180193e-01 | 0.928 |
R-HSA-9772572 | Early SARS-CoV-2 Infection Events | 1.584380e-01 | 0.800 |
R-HSA-69620 | Cell Cycle Checkpoints | 1.637124e-01 | 0.786 |
R-HSA-9793380 | Formation of paraxial mesoderm | 1.650247e-01 | 0.782 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 1.672091e-01 | 0.777 |
R-HSA-1268020 | Mitochondrial protein import | 1.672091e-01 | 0.777 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 1.737288e-01 | 0.760 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 1.758909e-01 | 0.755 |
R-HSA-6782315 | tRNA modification in the nucleus and cytosol | 1.758909e-01 | 0.755 |
R-HSA-5693606 | DNA Double Strand Break Response | 1.780475e-01 | 0.749 |
R-HSA-9958863 | SLC-mediated transport of amino acids | 1.780475e-01 | 0.749 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 1.801986e-01 | 0.744 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 1.801986e-01 | 0.744 |
R-HSA-446728 | Cell junction organization | 1.822929e-01 | 0.739 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 1.844843e-01 | 0.734 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 1.844843e-01 | 0.734 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 1.860487e-01 | 0.730 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 1.866190e-01 | 0.729 |
R-HSA-9638482 | Metal ion assimilation from the host | 1.866190e-01 | 0.729 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 1.866190e-01 | 0.729 |
R-HSA-453276 | Regulation of mitotic cell cycle | 1.866190e-01 | 0.729 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 1.887482e-01 | 0.724 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 1.887482e-01 | 0.724 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 1.887482e-01 | 0.724 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 1.908720e-01 | 0.719 |
R-HSA-9013694 | Signaling by NOTCH4 | 1.929903e-01 | 0.714 |
R-HSA-69473 | G2/M DNA damage checkpoint | 1.929903e-01 | 0.714 |
R-HSA-380287 | Centrosome maturation | 1.951032e-01 | 0.710 |
R-HSA-1169408 | ISG15 antiviral mechanism | 1.951032e-01 | 0.710 |
R-HSA-8852135 | Protein ubiquitination | 1.951032e-01 | 0.710 |
R-HSA-917937 | Iron uptake and transport | 1.951032e-01 | 0.710 |
R-HSA-1980143 | Signaling by NOTCH1 | 1.972107e-01 | 0.705 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 1.972107e-01 | 0.705 |
R-HSA-195721 | Signaling by WNT | 2.011832e-01 | 0.696 |
R-HSA-73864 | RNA Polymerase I Transcription | 2.014096e-01 | 0.696 |
R-HSA-9659379 | Sensory processing of sound | 2.035010e-01 | 0.691 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 2.055871e-01 | 0.687 |
R-HSA-9833482 | PKR-mediated signaling | 2.055871e-01 | 0.687 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 2.076678e-01 | 0.683 |
R-HSA-977225 | Amyloid fiber formation | 2.076678e-01 | 0.683 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 2.097432e-01 | 0.678 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 2.118133e-01 | 0.674 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 2.138781e-01 | 0.670 |
R-HSA-1500620 | Meiosis | 2.159376e-01 | 0.666 |
R-HSA-6802957 | Oncogenic MAPK signaling | 2.159376e-01 | 0.666 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 2.179918e-01 | 0.662 |
R-HSA-141424 | Amplification of signal from the kinetochores | 2.179918e-01 | 0.662 |
R-HSA-1500931 | Cell-Cell communication | 2.183856e-01 | 0.661 |
R-HSA-163841 | Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 2.200408e-01 | 0.657 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 2.241231e-01 | 0.650 |
R-HSA-9645723 | Diseases of programmed cell death | 2.241231e-01 | 0.650 |
R-HSA-9663891 | Selective autophagy | 2.241231e-01 | 0.650 |
R-HSA-73884 | Base Excision Repair | 2.281845e-01 | 0.642 |
R-HSA-68867 | Assembly of the pre-replicative complex | 2.362452e-01 | 0.627 |
R-HSA-2168880 | Scavenging of heme from plasma | 2.422367e-01 | 0.616 |
R-HSA-6807878 | COPI-mediated anterograde transport | 2.442236e-01 | 0.612 |
R-HSA-157579 | Telomere Maintenance | 2.462055e-01 | 0.609 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 2.462055e-01 | 0.609 |
R-HSA-3214847 | HATs acetylate histones | 2.501540e-01 | 0.602 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 2.521207e-01 | 0.598 |
R-HSA-1483255 | PI Metabolism | 2.560390e-01 | 0.592 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 2.560390e-01 | 0.592 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 2.599372e-01 | 0.585 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 2.618789e-01 | 0.582 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 2.618789e-01 | 0.582 |
R-HSA-418346 | Platelet homeostasis | 2.657472e-01 | 0.576 |
R-HSA-211000 | Gene Silencing by RNA | 2.676740e-01 | 0.572 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 2.676740e-01 | 0.572 |
R-HSA-9700206 | Signaling by ALK in cancer | 2.676740e-01 | 0.572 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 2.715127e-01 | 0.566 |
R-HSA-69002 | DNA Replication Pre-Initiation | 2.715127e-01 | 0.566 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 2.791312e-01 | 0.554 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 2.810237e-01 | 0.551 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 2.842267e-01 | 0.546 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 2.847941e-01 | 0.545 |
R-HSA-373760 | L1CAM interactions | 2.885451e-01 | 0.540 |
R-HSA-5693538 | Homology Directed Repair | 2.922770e-01 | 0.534 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 2.941358e-01 | 0.531 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 2.978390e-01 | 0.526 |
R-HSA-73886 | Chromosome Maintenance | 2.978390e-01 | 0.526 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 3.015233e-01 | 0.521 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 3.015233e-01 | 0.521 |
R-HSA-1280218 | Adaptive Immune System | 3.024976e-01 | 0.519 |
R-HSA-69206 | G1/S Transition | 3.070143e-01 | 0.513 |
R-HSA-69481 | G2/M Checkpoints | 3.106516e-01 | 0.508 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 3.160725e-01 | 0.500 |
R-HSA-1474165 | Reproduction | 3.178703e-01 | 0.498 |
R-HSA-9018519 | Estrogen-dependent gene expression | 3.303258e-01 | 0.481 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 3.355957e-01 | 0.474 |
R-HSA-1632852 | Macroautophagy | 3.390864e-01 | 0.470 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 3.442890e-01 | 0.463 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 3.494515e-01 | 0.457 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 3.511635e-01 | 0.454 |
R-HSA-69242 | S Phase | 3.528712e-01 | 0.452 |
R-HSA-9758941 | Gastrulation | 3.545744e-01 | 0.450 |
R-HSA-6798695 | Neutrophil degranulation | 3.555101e-01 | 0.449 |
R-HSA-2173782 | Binding and Uptake of Ligands by Scavenger Receptors | 3.562733e-01 | 0.448 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 3.613437e-01 | 0.442 |
R-HSA-69306 | DNA Replication | 3.613437e-01 | 0.442 |
R-HSA-9609507 | Protein localization | 3.613437e-01 | 0.442 |
R-HSA-73887 | Death Receptor Signaling | 3.630252e-01 | 0.440 |
R-HSA-9612973 | Autophagy | 3.663751e-01 | 0.436 |
R-HSA-5653656 | Vesicle-mediated transport | 3.682456e-01 | 0.434 |
R-HSA-2467813 | Separation of Sister Chromatids | 3.796039e-01 | 0.421 |
R-HSA-72306 | tRNA processing | 3.909576e-01 | 0.408 |
R-HSA-212436 | Generic Transcription Pathway | 3.921106e-01 | 0.407 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 3.941640e-01 | 0.404 |
R-HSA-5689880 | Ub-specific processing proteases | 3.957611e-01 | 0.403 |
R-HSA-9678108 | SARS-CoV-1 Infection | 3.989429e-01 | 0.399 |
R-HSA-69275 | G2/M Transition | 4.161525e-01 | 0.381 |
R-HSA-453274 | Mitotic G2-G2/M phases | 4.192295e-01 | 0.378 |
R-HSA-168898 | Toll-like Receptor Cascades | 4.238152e-01 | 0.373 |
R-HSA-389948 | Co-inhibition by PD-1 | 4.373613e-01 | 0.359 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 4.403291e-01 | 0.356 |
R-HSA-9640148 | Infection with Enterobacteria | 4.418072e-01 | 0.355 |
R-HSA-597592 | Post-translational protein modification | 4.492912e-01 | 0.347 |
R-HSA-68882 | Mitotic Anaphase | 4.621054e-01 | 0.335 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 4.635273e-01 | 0.334 |
R-HSA-73857 | RNA Polymerase II Transcription | 4.678038e-01 | 0.330 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 4.761610e-01 | 0.322 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 4.816823e-01 | 0.317 |
R-HSA-3247509 | Chromatin modifying enzymes | 4.871468e-01 | 0.312 |
R-HSA-8939211 | ESR-mediated signaling | 4.912082e-01 | 0.309 |
R-HSA-4839726 | Chromatin organization | 5.071422e-01 | 0.295 |
R-HSA-5688426 | Deubiquitination | 5.149255e-01 | 0.288 |
R-HSA-199991 | Membrane Trafficking | 5.253848e-01 | 0.280 |
R-HSA-9711123 | Cellular response to chemical stress | 5.313799e-01 | 0.275 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 5.508659e-01 | 0.259 |
R-HSA-5673001 | RAF/MAP kinase cascade | 5.568158e-01 | 0.254 |
R-HSA-1483257 | Phospholipid metabolism | 5.638322e-01 | 0.249 |
R-HSA-1257604 | PIP3 activates AKT signaling | 5.638322e-01 | 0.249 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 5.649910e-01 | 0.248 |
R-HSA-9824446 | Viral Infection Pathways | 5.837854e-01 | 0.234 |
R-HSA-1266738 | Developmental Biology | 5.952105e-01 | 0.225 |
R-HSA-74160 | Gene expression (Transcription) | 6.055685e-01 | 0.218 |
R-HSA-168256 | Immune System | 6.094666e-01 | 0.215 |
R-HSA-9006925 | Intracellular signaling by second messengers | 6.151672e-01 | 0.211 |
R-HSA-5683057 | MAPK family signaling cascades | 6.202679e-01 | 0.207 |
R-HSA-9694516 | SARS-CoV-2 Infection | 6.222897e-01 | 0.206 |
R-HSA-73894 | DNA Repair | 6.332230e-01 | 0.198 |
R-HSA-1643685 | Disease | 6.338671e-01 | 0.198 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 6.361508e-01 | 0.196 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 6.371216e-01 | 0.196 |
R-HSA-8953854 | Metabolism of RNA | 6.613613e-01 | 0.180 |
R-HSA-9824439 | Bacterial Infection Pathways | 6.623994e-01 | 0.179 |
R-HSA-5663205 | Infectious disease | 6.659020e-01 | 0.177 |
R-HSA-446203 | Asparagine N-linked glycosylation | 6.901379e-01 | 0.161 |
R-HSA-422475 | Axon guidance | 7.774971e-01 | 0.109 |
R-HSA-392499 | Metabolism of proteins | 7.801880e-01 | 0.108 |
R-HSA-9679506 | SARS-CoV Infections | 7.834332e-01 | 0.106 |
R-HSA-9675108 | Nervous system development | 7.986990e-01 | 0.098 |
R-HSA-168249 | Innate Immune System | 8.775301e-01 | 0.057 |
R-HSA-109582 | Hemostasis | 8.839700e-01 | 0.054 |
R-HSA-9709957 | Sensory Perception | 9.671691e-01 | 0.014 |
R-HSA-162582 | Signal Transduction | 9.697375e-01 | 0.013 |
R-HSA-556833 | Metabolism of lipids | 9.839588e-01 | 0.007 |
R-HSA-1430728 | Metabolism | 9.998077e-01 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
BMPR1B |
0.573 | 0.089 | 1 | 0.632 |
TGFBR1 |
0.568 | 0.109 | -2 | 0.598 |
JNK2 |
0.565 | 0.103 | 1 | 0.601 |
CLK3 |
0.565 | 0.033 | 1 | 0.679 |
KIS |
0.564 | 0.104 | 1 | 0.629 |
ERK5 |
0.563 | 0.116 | 1 | 0.777 |
MOS |
0.563 | 0.043 | 1 | 0.608 |
CDK8 |
0.561 | 0.108 | 1 | 0.624 |
CDK19 |
0.561 | 0.110 | 1 | 0.615 |
HIPK4 |
0.560 | 0.090 | 1 | 0.597 |
BMPR1A |
0.560 | 0.069 | 1 | 0.601 |
P38B |
0.559 | 0.091 | 1 | 0.672 |
JNK3 |
0.559 | 0.093 | 1 | 0.615 |
ALK2 |
0.558 | 0.075 | -2 | 0.591 |
P38D |
0.557 | 0.101 | 1 | 0.568 |
P38A |
0.557 | 0.098 | 1 | 0.688 |
CDC7 |
0.557 | 0.042 | 1 | 0.588 |
ALK4 |
0.557 | 0.078 | -2 | 0.585 |
DSTYK |
0.556 | 0.043 | 2 | 0.617 |
CLK2 |
0.556 | 0.037 | -3 | 0.129 |
ACVR2B |
0.555 | 0.040 | -2 | 0.554 |
PRKD1 |
0.554 | 0.065 | -3 | 0.200 |
NLK |
0.554 | 0.086 | 1 | 0.652 |
P38G |
0.553 | 0.073 | 1 | 0.581 |
DYRK2 |
0.552 | 0.064 | 1 | 0.630 |
PRPK |
0.550 | -0.011 | -1 | 0.639 |
CDKL5 |
0.550 | 0.023 | -3 | 0.170 |
ULK1 |
0.550 | 0.262 | -3 | 0.453 |
MTOR |
0.550 | 0.024 | 1 | 0.561 |
ERK1 |
0.549 | 0.078 | 1 | 0.651 |
BMPR2 |
0.549 | -0.046 | -2 | 0.537 |
SRPK1 |
0.549 | 0.011 | -3 | 0.135 |
GRK1 |
0.548 | -0.006 | -2 | 0.505 |
COT |
0.548 | -0.078 | 2 | 0.581 |
ACVR2A |
0.548 | 0.027 | -2 | 0.541 |
ICK |
0.548 | 0.011 | -3 | 0.197 |
CDK1 |
0.547 | 0.048 | 1 | 0.622 |
GRK7 |
0.547 | -0.024 | 1 | 0.564 |
MAPKAPK2 |
0.547 | 0.004 | -3 | 0.134 |
HIPK2 |
0.546 | 0.062 | 1 | 0.580 |
CLK1 |
0.546 | 0.025 | -3 | 0.141 |
CLK4 |
0.546 | 0.009 | -3 | 0.144 |
PIM3 |
0.546 | -0.028 | -3 | 0.160 |
CHAK2 |
0.546 | 0.022 | -1 | 0.657 |
JNK1 |
0.545 | 0.066 | 1 | 0.600 |
ATR |
0.545 | -0.018 | 1 | 0.510 |
HIPK1 |
0.545 | 0.047 | 1 | 0.636 |
CDKL1 |
0.544 | -0.033 | -3 | 0.171 |
DYRK4 |
0.544 | 0.064 | 1 | 0.604 |
ULK2 |
0.544 | 0.168 | 2 | 0.502 |
MAPKAPK3 |
0.543 | 0.001 | -3 | 0.165 |
CDK7 |
0.543 | 0.059 | 1 | 0.629 |
PDHK4 |
0.542 | -0.065 | 1 | 0.554 |
NEK9 |
0.542 | 0.135 | 2 | 0.559 |
MAK |
0.542 | 0.038 | -2 | 0.414 |
SRPK3 |
0.542 | -0.007 | -3 | 0.138 |
CAMK2D |
0.542 | 0.001 | -3 | 0.199 |
CDK18 |
0.542 | 0.057 | 1 | 0.609 |
LATS1 |
0.542 | -0.051 | -3 | 0.173 |
MPSK1 |
0.542 | 0.077 | 1 | 0.592 |
CK1D |
0.541 | -0.028 | -3 | 0.073 |
HIPK3 |
0.541 | 0.068 | 1 | 0.615 |
NEK6 |
0.541 | 0.003 | -2 | 0.519 |
CAMK1B |
0.541 | -0.064 | -3 | 0.185 |
PRP4 |
0.540 | -0.006 | -3 | 0.155 |
SRPK2 |
0.540 | -0.006 | -3 | 0.120 |
CAMK2G |
0.539 | -0.044 | 2 | 0.534 |
GRK5 |
0.539 | -0.091 | -3 | 0.183 |
CDK13 |
0.539 | 0.058 | 1 | 0.610 |
CDK5 |
0.539 | 0.047 | 1 | 0.647 |
PRKD2 |
0.539 | 0.002 | -3 | 0.162 |
IKKA |
0.539 | -0.040 | -2 | 0.431 |
NEK7 |
0.538 | -0.008 | -3 | 0.267 |
TGFBR2 |
0.538 | -0.006 | -2 | 0.543 |
GRK6 |
0.538 | -0.058 | 1 | 0.582 |
GAK |
0.538 | 0.069 | 1 | 0.678 |
PDHK1 |
0.537 | -0.025 | 1 | 0.531 |
RAF1 |
0.537 | -0.085 | 1 | 0.534 |
PIM1 |
0.537 | -0.038 | -3 | 0.137 |
CK1E |
0.537 | -0.027 | -3 | 0.087 |
CDK17 |
0.537 | 0.054 | 1 | 0.579 |
DAPK2 |
0.537 | -0.057 | -3 | 0.198 |
CDK3 |
0.536 | 0.050 | 1 | 0.599 |
PINK1 |
0.536 | 0.020 | 1 | 0.596 |
IKKB |
0.536 | -0.071 | -2 | 0.412 |
SKMLCK |
0.536 | -0.061 | -2 | 0.492 |
CAMLCK |
0.536 | -0.061 | -2 | 0.454 |
NUAK2 |
0.535 | -0.008 | -3 | 0.195 |
LKB1 |
0.535 | 0.062 | -3 | 0.265 |
CHK1 |
0.535 | -0.015 | -3 | 0.201 |
CAMK2A |
0.535 | -0.033 | 2 | 0.549 |
CAMK2B |
0.534 | -0.021 | 2 | 0.544 |
NIK |
0.534 | -0.107 | -3 | 0.195 |
CDK9 |
0.534 | 0.054 | 1 | 0.617 |
HUNK |
0.534 | -0.003 | 2 | 0.578 |
NDR2 |
0.534 | -0.057 | -3 | 0.163 |
MOK |
0.534 | 0.035 | 1 | 0.673 |
DYRK1B |
0.534 | 0.032 | 1 | 0.614 |
CK1A2 |
0.534 | -0.040 | -3 | 0.069 |
CAMKK2 |
0.534 | 0.069 | -2 | 0.394 |
GRK4 |
0.533 | -0.065 | -2 | 0.531 |
PKN3 |
0.533 | -0.018 | -3 | 0.249 |
FAM20C |
0.533 | 0.033 | 2 | 0.495 |
PBK |
0.533 | 0.079 | 1 | 0.662 |
GRK2 |
0.533 | -0.035 | -2 | 0.468 |
TLK2 |
0.533 | -0.031 | 1 | 0.458 |
CDK12 |
0.533 | 0.050 | 1 | 0.591 |
LATS2 |
0.533 | -0.054 | -5 | 0.500 |
MASTL |
0.532 | -0.083 | -2 | 0.447 |
MEK1 |
0.532 | -0.063 | 2 | 0.581 |
PASK |
0.532 | -0.042 | -3 | 0.181 |
DLK |
0.532 | -0.131 | 1 | 0.544 |
GCN2 |
0.531 | -0.046 | 2 | 0.535 |
DYRK1A |
0.531 | 0.019 | 1 | 0.612 |
RSK2 |
0.531 | -0.056 | -3 | 0.137 |
SBK |
0.531 | -0.021 | -3 | 0.091 |
GRK3 |
0.530 | -0.029 | -2 | 0.460 |
CK2A2 |
0.530 | 0.006 | 1 | 0.527 |
TLK1 |
0.530 | -0.026 | -2 | 0.590 |
VRK2 |
0.530 | -0.091 | 1 | 0.593 |
ERK2 |
0.529 | 0.035 | 1 | 0.631 |
NEK2 |
0.529 | 0.035 | 2 | 0.544 |
ATM |
0.529 | -0.027 | 1 | 0.443 |
CAMKK1 |
0.529 | 0.055 | -2 | 0.397 |
SMG1 |
0.529 | -0.011 | 1 | 0.455 |
PKR |
0.529 | -0.059 | 1 | 0.523 |
PLK1 |
0.529 | -0.029 | -2 | 0.457 |
BIKE |
0.528 | 0.113 | 1 | 0.658 |
MLK2 |
0.528 | -0.077 | 2 | 0.552 |
NEK5 |
0.528 | 0.037 | 1 | 0.526 |
PERK |
0.528 | -0.018 | -2 | 0.531 |
CDK10 |
0.528 | 0.033 | 1 | 0.612 |
PRKD3 |
0.528 | -0.033 | -3 | 0.155 |
BRAF |
0.527 | -0.049 | -4 | 0.095 |
MAPKAPK5 |
0.527 | -0.014 | -3 | 0.186 |
TBK1 |
0.527 | -0.084 | 1 | 0.443 |
DYRK3 |
0.527 | 0.005 | 1 | 0.615 |
PIM2 |
0.527 | -0.037 | -3 | 0.141 |
AAK1 |
0.527 | 0.122 | 1 | 0.628 |
YSK4 |
0.527 | -0.074 | 1 | 0.475 |
MST4 |
0.527 | -0.059 | 2 | 0.609 |
ANKRD3 |
0.527 | -0.107 | 1 | 0.540 |
RSK3 |
0.526 | -0.057 | -3 | 0.163 |
WNK1 |
0.526 | -0.066 | -2 | 0.487 |
IKKE |
0.526 | -0.078 | 1 | 0.434 |
P70S6KB |
0.526 | -0.081 | -3 | 0.152 |
P90RSK |
0.525 | -0.061 | -3 | 0.165 |
CDK14 |
0.525 | 0.032 | 1 | 0.622 |
AURC |
0.525 | -0.031 | -2 | 0.300 |
CDK16 |
0.525 | 0.032 | 1 | 0.589 |
GSK3A |
0.524 | -0.005 | 4 | 0.399 |
DNAPK |
0.524 | -0.014 | 1 | 0.368 |
CDK2 |
0.524 | 0.000 | 1 | 0.653 |
MLK1 |
0.523 | -0.124 | 2 | 0.523 |
NDR1 |
0.523 | -0.102 | -3 | 0.163 |
ERK7 |
0.523 | 0.015 | 2 | 0.326 |
BCKDK |
0.522 | -0.061 | -1 | 0.558 |
AKT2 |
0.522 | -0.050 | -3 | 0.120 |
GSK3B |
0.522 | -0.004 | 4 | 0.393 |
MARK4 |
0.522 | -0.048 | 4 | 0.545 |
HRI |
0.521 | -0.029 | -2 | 0.528 |
RSK4 |
0.521 | -0.067 | -3 | 0.139 |
TTBK2 |
0.520 | -0.091 | 2 | 0.459 |
DCAMKL1 |
0.520 | -0.069 | -3 | 0.157 |
CK1A |
0.520 | -0.036 | -3 | 0.047 |
BUB1 |
0.520 | 0.014 | -5 | 0.500 |
RIPK3 |
0.519 | -0.088 | 3 | 0.517 |
MEKK3 |
0.519 | -0.105 | 1 | 0.514 |
EEF2K |
0.519 | -0.014 | 3 | 0.616 |
NEK11 |
0.519 | -0.031 | 1 | 0.484 |
TSSK2 |
0.518 | -0.067 | -5 | 0.500 |
CK2A1 |
0.518 | -0.006 | 1 | 0.505 |
MSK1 |
0.518 | -0.056 | -3 | 0.145 |
AMPKA1 |
0.517 | -0.091 | -3 | 0.184 |
TSSK1 |
0.517 | -0.053 | -3 | 0.191 |
PKN2 |
0.517 | -0.100 | -3 | 0.174 |
PLK3 |
0.517 | -0.066 | 2 | 0.515 |
CHAK1 |
0.517 | -0.041 | 2 | 0.562 |
PKACG |
0.517 | -0.079 | -2 | 0.347 |
MEKK6 |
0.517 | -0.003 | 1 | 0.537 |
MEKK2 |
0.517 | -0.100 | 2 | 0.521 |
MEK5 |
0.516 | -0.145 | 2 | 0.550 |
RIPK1 |
0.516 | -0.107 | 1 | 0.476 |
MST2 |
0.516 | -0.095 | 1 | 0.525 |
PKACB |
0.516 | -0.061 | -2 | 0.305 |
MST3 |
0.515 | -0.088 | 2 | 0.587 |
PLK2 |
0.515 | -0.046 | -3 | 0.220 |
GCK |
0.514 | -0.078 | 1 | 0.521 |
CDK6 |
0.514 | 0.031 | 1 | 0.607 |
DRAK1 |
0.514 | -0.064 | 1 | 0.504 |
SMMLCK |
0.514 | -0.077 | -3 | 0.176 |
MEKK1 |
0.513 | -0.109 | 1 | 0.497 |
TAK1 |
0.513 | -0.078 | 1 | 0.506 |
SGK3 |
0.513 | -0.071 | -3 | 0.138 |
PAK1 |
0.513 | -0.093 | -2 | 0.393 |
NEK1 |
0.513 | 0.030 | 1 | 0.486 |
AURA |
0.513 | -0.061 | -2 | 0.279 |
MYLK4 |
0.513 | -0.078 | -2 | 0.399 |
MLK3 |
0.513 | -0.107 | 2 | 0.458 |
TNIK |
0.512 | -0.043 | 3 | 0.662 |
CHK2 |
0.512 | -0.052 | -3 | 0.106 |
AMPKA2 |
0.512 | -0.086 | -3 | 0.163 |
TAO3 |
0.512 | -0.128 | 1 | 0.500 |
MINK |
0.512 | -0.051 | 1 | 0.490 |
MNK2 |
0.512 | -0.070 | -2 | 0.386 |
NEK4 |
0.512 | 0.007 | 1 | 0.470 |
CAMK4 |
0.511 | -0.102 | -3 | 0.179 |
MLK4 |
0.511 | -0.120 | 2 | 0.438 |
HPK1 |
0.511 | -0.059 | 1 | 0.493 |
NUAK1 |
0.510 | -0.039 | -3 | 0.174 |
CK1G1 |
0.510 | -0.065 | -3 | 0.072 |
NEK3 |
0.510 | 0.060 | 1 | 0.456 |
AURB |
0.510 | -0.059 | -2 | 0.287 |
PAK3 |
0.510 | -0.089 | -2 | 0.391 |
CDK4 |
0.510 | 0.021 | 1 | 0.582 |
DAPK1 |
0.510 | -0.065 | -3 | 0.144 |
PRKX |
0.510 | -0.063 | -3 | 0.097 |
SGK1 |
0.509 | -0.055 | -3 | 0.091 |
DAPK3 |
0.509 | -0.079 | -3 | 0.150 |
MEK2 |
0.509 | -0.019 | 2 | 0.545 |
PAK6 |
0.509 | -0.037 | -2 | 0.304 |
HGK |
0.509 | -0.044 | 3 | 0.652 |
MSK2 |
0.509 | -0.093 | -3 | 0.144 |
ZAK |
0.509 | -0.135 | 1 | 0.476 |
PKCD |
0.509 | -0.114 | 2 | 0.477 |
LRRK2 |
0.508 | -0.085 | 2 | 0.563 |
PDK1 |
0.508 | -0.093 | 1 | 0.477 |
NIM1 |
0.508 | -0.073 | 3 | 0.558 |
MAP3K15 |
0.508 | -0.075 | 1 | 0.466 |
WNK4 |
0.507 | -0.085 | -2 | 0.475 |
PKCB |
0.507 | -0.082 | 2 | 0.442 |
QSK |
0.507 | -0.065 | 4 | 0.514 |
DCAMKL2 |
0.507 | -0.087 | -3 | 0.166 |
PKACA |
0.507 | -0.064 | -2 | 0.278 |
WNK3 |
0.507 | -0.161 | 1 | 0.487 |
NEK8 |
0.507 | -0.084 | 2 | 0.524 |
CRIK |
0.506 | -0.054 | -3 | 0.131 |
P70S6K |
0.506 | -0.073 | -3 | 0.140 |
CAMK1D |
0.505 | -0.085 | -3 | 0.113 |
IRE1 |
0.504 | -0.110 | 1 | 0.484 |
PKG2 |
0.504 | -0.081 | -2 | 0.298 |
PKCA |
0.503 | -0.100 | 2 | 0.440 |
PKCZ |
0.503 | -0.106 | 2 | 0.495 |
PHKG1 |
0.503 | -0.097 | -3 | 0.158 |
TAO2 |
0.503 | -0.127 | 2 | 0.552 |
SIK |
0.502 | -0.080 | -3 | 0.156 |
MELK |
0.502 | -0.116 | -3 | 0.159 |
QIK |
0.502 | -0.108 | -3 | 0.191 |
MARK2 |
0.502 | -0.068 | 4 | 0.447 |
CK1G2 |
0.502 | -0.040 | -3 | 0.055 |
PKCG |
0.501 | -0.110 | 2 | 0.442 |
PAK2 |
0.501 | -0.116 | -2 | 0.368 |
PLK4 |
0.501 | -0.103 | 2 | 0.372 |
MST1 |
0.501 | -0.134 | 1 | 0.491 |
KHS1 |
0.501 | -0.069 | 1 | 0.477 |
OSR1 |
0.500 | -0.114 | 2 | 0.545 |
IRAK1 |
0.500 | -0.078 | -1 | 0.529 |
ROCK2 |
0.500 | -0.085 | -3 | 0.141 |
MRCKB |
0.500 | -0.081 | -3 | 0.128 |
MARK3 |
0.500 | -0.072 | 4 | 0.453 |
KHS2 |
0.500 | -0.066 | 1 | 0.490 |
AKT3 |
0.499 | -0.062 | -3 | 0.101 |
MNK1 |
0.499 | -0.105 | -2 | 0.391 |
CAMK1G |
0.499 | -0.096 | -3 | 0.170 |
PKCH |
0.499 | -0.114 | 2 | 0.425 |
AKT1 |
0.498 | -0.076 | -3 | 0.121 |
DMPK1 |
0.498 | -0.077 | -3 | 0.124 |
BRSK1 |
0.497 | -0.087 | -3 | 0.169 |
VRK1 |
0.496 | -0.141 | 2 | 0.542 |
LOK |
0.496 | -0.099 | -2 | 0.383 |
YSK1 |
0.496 | -0.073 | 2 | 0.539 |
MRCKA |
0.496 | -0.095 | -3 | 0.130 |
MARK1 |
0.496 | -0.080 | 4 | 0.470 |
IRAK4 |
0.495 | -0.115 | 1 | 0.478 |
CAMK1A |
0.495 | -0.079 | -3 | 0.112 |
PKCI |
0.494 | -0.080 | 2 | 0.461 |
PAK5 |
0.494 | -0.069 | -2 | 0.268 |
ALPHAK3 |
0.493 | -0.078 | -1 | 0.608 |
IRE2 |
0.493 | -0.134 | 2 | 0.438 |
TTBK1 |
0.493 | -0.105 | 2 | 0.388 |
PKCE |
0.492 | -0.088 | 2 | 0.444 |
SLK |
0.492 | -0.119 | -2 | 0.356 |
BRSK2 |
0.491 | -0.110 | -3 | 0.171 |
MYO3B |
0.491 | -0.044 | 2 | 0.556 |
CK1G3 |
0.490 | -0.079 | -3 | 0.033 |
TTK |
0.490 | -0.102 | -2 | 0.509 |
HASPIN |
0.490 | -0.040 | -1 | 0.538 |
SSTK |
0.489 | -0.095 | 4 | 0.499 |
PAK4 |
0.489 | -0.062 | -2 | 0.280 |
ASK1 |
0.489 | -0.088 | 1 | 0.452 |
STK33 |
0.489 | -0.085 | 2 | 0.390 |
SNRK |
0.488 | -0.123 | 2 | 0.392 |
BMPR2_TYR |
0.488 | 0.010 | -1 | 0.713 |
PKN1 |
0.488 | -0.080 | -3 | 0.145 |
MAP2K4_TYR |
0.487 | 0.033 | -1 | 0.658 |
MAP2K6_TYR |
0.485 | -0.011 | -1 | 0.679 |
PDHK3_TYR |
0.485 | -0.034 | 4 | 0.675 |
PKCT |
0.484 | -0.124 | 2 | 0.427 |
ROCK1 |
0.484 | -0.100 | -3 | 0.129 |
PDHK1_TYR |
0.484 | -0.002 | -1 | 0.696 |
RIPK2 |
0.481 | -0.129 | 1 | 0.419 |
BLK |
0.481 | 0.053 | -1 | 0.652 |
MYO3A |
0.481 | -0.107 | 1 | 0.445 |
EPHA6 |
0.480 | 0.023 | -1 | 0.689 |
PHKG2 |
0.479 | -0.114 | -3 | 0.163 |
PKMYT1_TYR |
0.479 | -0.019 | 3 | 0.653 |
PKG1 |
0.478 | -0.068 | -2 | 0.250 |
PTK2 |
0.478 | 0.043 | -1 | 0.684 |
LCK |
0.478 | 0.022 | -1 | 0.645 |
STLK3 |
0.477 | -0.141 | 1 | 0.436 |
EPHB4 |
0.476 | 0.002 | -1 | 0.617 |
YANK3 |
0.476 | -0.073 | 2 | 0.255 |
EPHA4 |
0.475 | -0.006 | 2 | 0.539 |
FGR |
0.475 | -0.009 | 1 | 0.677 |
HCK |
0.475 | 0.028 | -1 | 0.623 |
FYN |
0.475 | 0.009 | -1 | 0.625 |
SYK |
0.475 | 0.015 | -1 | 0.667 |
ABL2 |
0.474 | 0.019 | -1 | 0.591 |
SRMS |
0.474 | 0.007 | 1 | 0.633 |
TXK |
0.473 | -0.024 | 1 | 0.648 |
PDHK4_TYR |
0.473 | -0.117 | 2 | 0.615 |
TESK1_TYR |
0.473 | -0.102 | 3 | 0.673 |
TAO1 |
0.472 | -0.132 | 1 | 0.412 |
EPHB2 |
0.471 | -0.002 | -1 | 0.605 |
ABL1 |
0.471 | 0.014 | -1 | 0.574 |
LIMK2_TYR |
0.469 | -0.068 | -3 | 0.195 |
FER |
0.469 | -0.031 | 1 | 0.662 |
EPHB3 |
0.468 | -0.013 | -1 | 0.601 |
TNK2 |
0.468 | 0.003 | 3 | 0.563 |
MAP2K7_TYR |
0.468 | -0.210 | 2 | 0.585 |
YES1 |
0.467 | -0.043 | -1 | 0.589 |
EPHB1 |
0.466 | -0.035 | 1 | 0.624 |
SRC |
0.465 | -0.012 | -1 | 0.591 |
ITK |
0.465 | -0.047 | -1 | 0.579 |
PINK1_TYR |
0.464 | -0.190 | 1 | 0.556 |
LYN |
0.463 | -0.009 | 3 | 0.523 |
BMX |
0.461 | -0.034 | -1 | 0.518 |
EPHA8 |
0.460 | -0.025 | -1 | 0.628 |
EPHA7 |
0.460 | -0.034 | 2 | 0.522 |
PTK2B |
0.459 | -0.012 | -1 | 0.517 |
JAK2 |
0.458 | -0.083 | 1 | 0.509 |
EPHA3 |
0.458 | -0.051 | 2 | 0.496 |
LIMK1_TYR |
0.457 | -0.153 | 2 | 0.569 |
YANK2 |
0.457 | -0.084 | 2 | 0.264 |
DDR1 |
0.457 | -0.114 | 4 | 0.583 |
RET |
0.457 | -0.147 | 1 | 0.503 |
EPHA5 |
0.456 | -0.032 | 2 | 0.510 |
MST1R |
0.456 | -0.121 | 3 | 0.611 |
MERTK |
0.455 | -0.049 | 3 | 0.579 |
MET |
0.455 | -0.088 | 3 | 0.587 |
TYK2 |
0.454 | -0.121 | 1 | 0.503 |
CSF1R |
0.453 | -0.121 | 3 | 0.585 |
EGFR |
0.453 | -0.050 | 1 | 0.458 |
FRK |
0.453 | -0.053 | -1 | 0.652 |
TYRO3 |
0.453 | -0.132 | 3 | 0.582 |
BTK |
0.453 | -0.067 | -1 | 0.516 |
INSRR |
0.453 | -0.100 | 3 | 0.521 |
EPHA2 |
0.452 | -0.026 | -1 | 0.612 |
JAK3 |
0.452 | -0.115 | 1 | 0.487 |
ROS1 |
0.452 | -0.124 | 3 | 0.547 |
ERBB4 |
0.451 | -0.029 | 1 | 0.509 |
ERBB2 |
0.450 | -0.081 | 1 | 0.509 |
KIT |
0.450 | -0.115 | 3 | 0.586 |
TNNI3K_TYR |
0.450 | -0.051 | 1 | 0.557 |
FLT1 |
0.450 | -0.108 | -1 | 0.681 |
JAK1 |
0.449 | -0.041 | 1 | 0.445 |
ZAP70 |
0.449 | -0.029 | -1 | 0.587 |
TEC |
0.449 | -0.069 | -1 | 0.486 |
FGFR2 |
0.449 | -0.136 | 3 | 0.585 |
NTRK1 |
0.449 | -0.098 | -1 | 0.565 |
CSK |
0.448 | -0.076 | 2 | 0.519 |
NTRK3 |
0.447 | -0.085 | -1 | 0.528 |
TEK |
0.447 | -0.111 | 3 | 0.520 |
EPHA1 |
0.446 | -0.069 | 3 | 0.576 |
NEK10_TYR |
0.445 | -0.075 | 1 | 0.372 |
PTK6 |
0.445 | -0.109 | -1 | 0.482 |
MATK |
0.444 | -0.093 | -1 | 0.537 |
FLT3 |
0.444 | -0.126 | 3 | 0.593 |
KDR |
0.443 | -0.143 | 3 | 0.552 |
FGFR1 |
0.443 | -0.130 | 3 | 0.554 |
AXL |
0.442 | -0.115 | 3 | 0.556 |
FGFR3 |
0.442 | -0.124 | 3 | 0.553 |
FGFR4 |
0.441 | -0.090 | -1 | 0.568 |
TNK1 |
0.441 | -0.100 | 3 | 0.585 |
LTK |
0.439 | -0.097 | 3 | 0.549 |
PDGFRB |
0.439 | -0.162 | 3 | 0.585 |
INSR |
0.438 | -0.109 | 3 | 0.505 |
NTRK2 |
0.437 | -0.129 | 3 | 0.526 |
ALK |
0.437 | -0.112 | 3 | 0.512 |
FLT4 |
0.436 | -0.139 | 3 | 0.549 |
FES |
0.436 | -0.043 | -1 | 0.475 |
WEE1_TYR |
0.435 | -0.103 | -1 | 0.514 |
PDGFRA |
0.434 | -0.161 | 3 | 0.589 |
MUSK |
0.434 | -0.055 | 1 | 0.457 |
DDR2 |
0.433 | -0.107 | 3 | 0.513 |
IGF1R |
0.433 | -0.085 | 3 | 0.452 |